North Korea-linked hackers targeted J&J, Novavax in hunt for Covid research


A nurse prepares a shot as a study of a possible Covid-19 vaccine, developed by the National Institutes of Health and Moderna Inc, gets underway in Binghamton, N.Y. Microsoft says state-backed Russian and North Korean hackers have in recent months tried to steal valuable data from leading pharmaceutical companies and Covid-19 vaccine researchers. — AP

WASHINGTON/LONDON: Suspected North Korean hackers have recently tried to break into at least nine health organisations, including pharmaceutical giant Johnson & Johnson and vaccine developer Novavax Inc, revealing a broader effort to target key players in the race to develop treatments for Covid-19.

Four people who have investigated the attacks said the spate of hacking attempts began in September, and used web domains mimicking online login portals to try and trick staff at the targeted organisations into revealing their passwords.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Tech News

Tesla increases wages for staff at German gigafactory by 4%
Apple explores push into smart glasses with ‘Atlas’ user study
Japan's Kioxia sees flash memory demand almost tripling by 2028
Hacker gets into woman’s email, changes every password, tries to make purchases
Foxconn says Oct revenue +8.59% y/y, Q4 outlook good
Want to help a friend find love? Give a PowerPoint presentation
Can an Apple�Watch get AFib patients off bloodthinners?
South Korea fines Meta about $15 million over collection of user data
Ehailing service Bolt says it’s launching in Malaysia soon, already licensed by Apad
French IT firm Atos agrees to sell Worldgrid unit to Alten

Others Also Read